Schizophrenia Research
Volume 95, Issue 1 , Pages 9-18 , September 2007

Changing incidence of psychotic disorders among the young in Zurich

  • Vladeta Ajdacic-Gross

      Affiliations

    • Research Unit for Clinical and Social Psychiatry, Psychiatric University Hospital, Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Research Unit for Clinical and Social Psychiatry, Psychiatric University Hospital, Militärstr. 8, PO Box 1930, CH-8021 Zürich, Switzerland. Tel.: +41 442967433; fax: +41 442967449.
    • ,
  • Christoph Lauber

      Affiliations

    • Research Unit for Clinical and Social Psychiatry, Psychiatric University Hospital, Zurich, Switzerland
    • ,
  • Inge Warnke

      Affiliations

    • Research Unit for Clinical and Social Psychiatry, Psychiatric University Hospital, Zurich, Switzerland
    • ,
  • Helene Haker

      Affiliations

    • Research Unit for Clinical and Social Psychiatry, Psychiatric University Hospital, Zurich, Switzerland
    • ,
  • Robin M. Murray

      Affiliations

    • Institute of Psychiatry, King's College London, London, United Kingdom
    • ,
  • Wulf Rössler

      Affiliations

    • Research Unit for Clinical and Social Psychiatry, Psychiatric University Hospital, Zurich, Switzerland

Received 3 April 2006 ,Revised 8 June 2007 ,Accepted 10 June 2007.

References 

  1. Allardyce J, Morrison G, Van Os J, Kelly J, Murray RM, McCreadie RG. Schizophrenia is not disappearing in south-west Scotland. Br. J. Psychiatry. 2000;177:38–41
  2. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br. Med. J. 2002;325:1212–1213
  3. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry. 2004;184:110–117
  4. Box GEP, Jenkins GM. Time Series Analysis: Forecasting and Control. San Francisco: Holden-Day; 1970;
  5. Boydell J, Van Os J, Lambri M, Castle D, Allardyce J, McCreadie RG, et al. Incidence of schizophrenia in south-east London between 1965 and 1997. Br. J. Psychiatry. 2003;182:45–49
  6. Boydell J, van Os J, Caspi A, Kennedy N, Giouroukou E, Fearon P, et al. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychol. Med. 2006;36:1441–1446
  7. Brewin J, Cantwell R, Dalkin T, Fox R, Medley I, Glazebrook C, et al. Incidence of schizophrenia in Nottingham. A comparison of two cohorts, 1978–80 and 1992–94. Br. J. Psychiatry. 1997;171:140–144
  8. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry. 2005;57:1117–1127
  9. Clayton D, Schifflers E. Models for temporal variation in cancer rates, I: age-period and age-cohort models. Stat. Med. 1987;6:449–467
  10. Clayton D, Schifflers E. Models for temporal variation in cancer rates, II: age-period-cohort models. Stat. Med. 1987;6:469–481
  11. Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology (Berl). 2004;173:398–404
  12. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend. 2003;71:37–48
  13. Delgrande Jordan M, Kuntsche E, Schmid H, Kuendig H. Trends im Substanzkonsum von Jugendlichen in der Schweiz [Trends in substance use pattern among adolescents in Switzerland]. Paediatrica. 2004;15:34–35
  14. De Preux E, Dubois-Arber F, Zobel F. Current trends in illegal drug use and drug related health problems in Switzerland. Swiss Med. Wkly. 2004;134:313–321
  15. Der G, Gupta S, Murray RM. Is schizophrenia disappearing?. Lancet. 1990;335:513–516
  16. Drewe M, Drewe J, Riecher-Rossler A. Cannabis and risk of psychosis. Swiss Med. Wkly. 2004;134:659–663
  17. Eagles JM, Whalley LJ. Decline in the diagnosis of schizophrenia among first admissions to Scottish mental hospitals from 1969–78. Br. J. Psychiatry. 1985;146:151–154
  18. Eagles JM, Hunter D, McCance C. Decline in the diagnosis of schizophrenia among first contacts with psychiatric services in north-east Scotland, 1969–1984. Br. J. Psychiatry. 1988;152:793–798
  19. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol. Med. 2003;33:15–21
  20. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction. 2005;100:354–366
  21. Fienberg SE, Mason WM. Specification and implementation of age, period and cohort models. In:  Mason WM,  Fienberg SE editor. Cohort Analysis in Social Research. New York: Springer; 1985;p. 44–87
  22. Geddes JR, Black RJ, Whalley LJ, Eagles JM. Persistence of the decline in the diagnosis of schizophrenia among first admissions to Scottish hospitals from 1969 to 1988. Br. J. Psychiatry. 1993;163:620–626
  23. Gottman JM. Time-series analysis. Cambridge: Cambridge University Press; 1981;
  24. Hall W, Degenhardt L, Teesson M. Cannabis use and psychotic disorders: an update. Drug Alcohol Rev. 2004;23:433–443
  25. Harrison G, Cooper JE, Gancarczyk R. Changes in the administrative incidence of schizophrenia. Br. J. Psychiatry. 1991;159:811–816
  26. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. Br. Med. J. 2005;330:11
  27. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr. Bull. 2005;31:608–612
  28. Holford TR. An alternative approach to statistical age-period-cohort analysis. J. Chronic. Dis. 1985;38:831–836
  29. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu. Rev. Public Health. 1991;12:425–457
  30. Jones IH, Kirkby KC, Hay DA, Daniels BA, Longmore LM. Decline in diagnoses of schizophrenia in Tasmania during the period 1965–1990. Acta Psychiatr. Scand. 1997;95:13–18
  31. Kendell RE, Malcolm DE, Adams W. The problem of detecting changes in the incidence of schizophrenia. Br. J. Psychiatry. 1993;162:212–218
  32. Kuntsche EN. Progression of a general substance use pattern among adolescents in Switzerland? Investigating the relationship between alcohol, tobacco, and cannabis use over a 12-year period. Eur. Addict. Res. 2004;10:118–125
  33. Lauber C, Lay B, Rossler W. Homelessness among people with severe mental illness in Switzerland. Swiss Med. Wkly. 2005;135:50–56
  34. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 2004;363:1579–1588
  35. Macleod J, Davey Smith G, Hickman M. Does cannabis use cause schizophrenia?. Lancet. 2006;367:1055
  36. Maki P, Veijola J, Jones PB, Murray GK, Koponen H, Tienari P, et al. Predictors of schizophrenia — a review. Br. Med. Bull. 2005;73:1–15
  37. McCormick S, Goff DC. Apparent decrease in schizophrenia. Br. J. Psychiatry. 1991;159:725
  38. McGrath JJ. Myths and plain truths about schizophrenia epidemiology — the NAPE lecture 2004. Acta Psychiatr. Scand. 2005;111:4–11
  39. Munk-Jorgensen P, Mortensen PB. Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971–87. Br. J. Psychiatry. 1992;161:489–495
  40. Narring F, Tschumper A, Inderwildi Bonivento L, Jeannin A, Addor V, Bütikofer A, et al. SMASH 2002: Swiss multicenter adolescent survey on health 2002. In: Raisons de santé. Lausanne: Institut universitaire de médecine sociale et préventive; 2004;
  41. Oldehinkel AJ, Giel R. Time trends in the care-based incidence of schizophrenia. Br. J. Psychiatry. 1995;167:777–782
  42. Osby U, Hammar N, Brandt L, Wicks S, Thinsz Z, Ekbom A, et al. Time trends in first admissions for schizophrenia and paranoid psychosis in Stockholm County, Sweden. Schizophr. Res. 2001;47:247–254
  43. Preti A, Miotto P. Increase in first admissions for schizophrenia and other major psychoses in Italy. Psychiatry Res. 2000;94:139–152
  44. Rey JM, Tennant CC. Cannabis and mental health. Br. Med. J. 2002;325:1183–1184
  45. SAS Institute Inc. . SAS for Macintosh, Version 6.12. Cary, NC: SAS Institute Inc.; 1996;
  46. Suvisaari JM, Haukka JK, Tanskanen AJ, Lonnqvist JK. Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Arch. Gen. Psychiatry. 1999;56:733–740
  47. Takei N, Lewis G, Sham PC, Murray RM. Age-period-cohort analysis of the incidence of schizophrenia in Scotland. Psychol. Med. 1996;26:963–973
  48. Tsuchiya KJ, Munk-Jorgensen P. First-admission rates of schizophrenia in Denmark, 1980–1997: have they been increasing?. Schizophr. Res. 2002;54:187–191
  49. Van Kampen J, Katz M. Persistent psychosis after a single ingestion of ‘ecstasy’. Psychosomatics. 2001;42:525–527
  50. van Os J. Does the urban environment cause psychosis?. Br. J. Psychiatry. 2004;184:287–288
  51. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am. J. Epidemiol. 2002;156:319–327
  52. von Sydow K, Lieb R, Pfister H, Hofler M, Wittchen HU. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults — a transient phenomenon? Results from a longitudinal community study. Drug Alcohol Depend. 2002;66:147–159
  53. Waddington JL, Youssef HA. Evidence for a gender-specific decline in the rate of schizophrenia in rural Ireland over a 50-year period. Br. J. Psychiatry. 1994;164:171–176
  54. Woogh C. Is schizophrenia on the decline in Canada?. Can. J. Psychiatry. 2001;46:61–67
  55. Zammit S, Lewis G. Exploring the relationship between cannabis use and psychosis. Addiction. 2004;99:1353–1355

PII: S0920-9964(07)00242-3

doi: 10.1016/j.schres.2007.06.001

Schizophrenia Research
Volume 95, Issue 1 , Pages 9-18 , September 2007

Article Tools

* Image Usage & Resolution